Federal Register / Vol. 87, No. 46 / Wednesday, March 9, 2022 / Notices 13301 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2022–04980 Filed 3–8–22; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Vaccines Federal Implementation Plan, 

Request for Comments; Correction 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice; correction. 

SUMMARY: The Office of the Assistant 

Secretary for Health published a 

document in the Federal Register of 

March 2, 2022, announcing the request 

for comments for the Vaccines Federal 

Implementation Plan. The document 

includes a weblink where the Vaccines 

Federal Implementation Plan can be 

found: https://www.hhs.gov/vaccines/

vaccines-national-strategic-plan/

vaccines-federal-implementation-plan/

index.html#:∼:text=The%20Vaccines

%20Federal%20Implementation

%20Plan%20outlines%20specific

%20actions%20that%20federal,

National%20Strategic%20Plan

%202021%2D2025.&text=The

%20public%20comment%20period

%20for,2%2C%202022%20at%209

%20a.m. 

FOR FURTHER INFORMATION CONTACT: Dr. 

David Kim, Director, Division of 

Vaccines, U.S. Department of Health 

and Human Services, Office of the 

Assistant Secretary for Health, Room 

L616, Switzer Building, 330 C St. SW, 

Washington, DC 20024. Phone: 202– 

795–7697; Email: nvp.rfi@hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Correction 

In the Federal Register of March 2, 

2022, in FR Doc. 2022–04327, on page 

11724, in the second column, correct 

the subject line Meeting of the Vaccines 

Federal Implementation Plan to read, 

‘‘Vaccines Federal Implementation Plan, 

Request for Comments’’. We also 

inadvertently omitted the weblink 

where the implementation plan is 

located and can be found at https://

www.hhs.gov/vaccines/vaccinesnational-strategic-plan/vaccinesfederal-implementation-plan/

index.html#:∼:text=The%20Vaccines

%20Federal%20Implementation

%20Plan%20outlines%20specific

%20actions%20that%20federal,

National%20Strategic%20Plan

%202021%2D2025.&text=The

%20public%20comment%20period

%20for,2%2C%202022%20at%209

%20a.m. 

Dated: March 2, 2022. 

David Kim, 

Director, Division of Vaccines, Office of the 

Assistant Secretary for Health. 

[FR Doc. 2022–04937 Filed 3–8–22; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Neurodegeneration and Drug 

Discovery. 

Date: April 5, 2022. 

Time: 12:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Christine Jean DiDonato, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1014J, 

Bethesda, MD 20892, (301) 435–1042, 

didonatocj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

International and Cooperative Projects for 

Global Emerging Leaders Award. 

Date: April 6, 2022. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Seetha Bhagavan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5194, 

MSC 7846, Bethesda, MD 20892, (301) 237– 

9838, bhagavas@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Special 

Topics: Micro Physiological Systems and 

Implanted Devices. 

Date: April 6, 2022. 

Time: 12:00 p.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Robert C. Elliott, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3130, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

3009, elliotro@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Transplantation and Autoimmunity. 

Date: April 6, 2022. 

Time: 12:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Shiv A. Prasad, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5220, 

MSC 7852, Bethesda, MD 20892, (301) 443– 

5779, prasads@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: March 4, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–04984 Filed 3–8–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 


jspears on DSK121TN23PROD with NOTICES1